SiSaf has raised more than $12 million to date, of which $7 million has been announced over the last six months.

Belfast biotechnology start-up SiSaf has increased its interim funding to $6.8 million following a new strategic partnership with FTSE-100 listed comp(...)

Dr Suzanne Saffie-Siebert: Sisaf founder and chief executive

Sisaf, an innovative biopharmaceutical company with offices in Belfast and the south of England, has closed a $4.3 million (€3.69m) funding round at t(...)

SiSaf has created a revenue generating bio-courier technology branded as ProSilic

SiSaf, a Belfast biotechnology company, has closed a $4.3 million (€3.7 million) interim investment round to bring total fundraising to date to over $(...)